We provide you with 20 years of free, institutional-grade data for TCDA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TCDA. Explore the full financial landscape of TCDA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Tricida, Inc(NASDAQ:TCDA) 
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gas...
Website: http://www.tricida.com
Founded: 2013
Full Time Employees: 64 (May 2021)
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about TCDA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.